Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Predictive models for breast cancer susceptibility from multiple single nucleotide polymorphisms.

Jennifer Listgarten1, Sambasivarao Damaraju, Brett Poulin

  • 1Cross Cancer Institute of the Alberta Cancer Board, Edmonton, Alberta, Canada.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|April 23, 2004
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The MassBank contributions of the mFam collaboration.

Metabolomics : Official journal of the Metabolomic Society·2026
Same author

How artificial intelligence is reengineering protein engineering.

Science (New York, N.Y.)·2026
Same author

Structural ontogeny of protein-protein interactions.

Science (New York, N.Y.)·2026
Same author

Effects of alendronate and vitamin D on plasma metabolomic profiles in a rat model of osteoporosis.

Journal of pharmacological and toxicological methods·2025
Same author

Perceived challenges and solutions to providing rural physical therapy services: A qualitative inquiry of provider experience.

Physiotherapy theory and practice·2025
Same author

Pathways Contributing to Chemotherapy-Induced Myotoxicity Are Attenuated by EPA + DHA in a Clinically Relevant Model of Colorectal Cancer.

Journal of cachexia, sarcopenia and muscle·2025

This study identified three key single nucleotide polymorphisms (SNPs) that, when analyzed together using machine learning, can predict breast cancer risk with 69% accuracy. This multi-SNP approach shows promise for developing clinical tools for early cancer detection.

Area of Science:

  • Genetics and Genomics
  • Computational Biology
  • Oncology

Background:

  • Cancer development involves both genetic predisposition and environmental factors.
  • Sporadic cancer cases highlight the critical role of environmental influences in cancer risk.
  • Understanding genetic polymorphisms is crucial for assessing breast cancer risk.

Purpose of the Study:

  • To investigate the influence of genetic polymorphisms on breast cancer risk.
  • To identify specific single nucleotide polymorphisms (SNPs) that discriminate between breast cancer patients and healthy controls.
  • To evaluate the predictive power of machine learning models in breast cancer risk assessment.

Main Methods:

  • Measured 98 single nucleotide polymorphisms (SNPs) across 45 relevant genes in 174 breast cancer patients and matched controls.

Related Experiment Videos

  • Applied machine learning techniques including Support Vector Machines (SVMs), decision trees, and Naïve Bayes classifiers.
  • Compared the predictive accuracy of individual SNPs versus combinations of SNPs.

    • Main Results:

    • Identified a subset of three SNPs that effectively discriminate between breast cancer patients and controls.
    • Support Vector Machines achieved a maximum predictive power of 69% in distinguishing cases from controls.
    • No single SNP alone exceeded 60% predictive accuracy; combinations of SNPs demonstrated superior predictive capability.

    Conclusions:

    • Multiple single nucleotide polymorphisms (SNPs) from diverse genes collectively offer better predictive accuracy for identifying breast cancer patients than individual SNPs.
    • The identified SNPs (CYP11B2, CYP1B1, BCL6) are key discriminators of breast cancer risk.
    • Advancements in high-throughput SNP technology may lead to highly accurate clinical tools for breast cancer prediction.